NCT06078267View on ClinicalTrials.gov

Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure (Beta Study)

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 12, 2024

Primary Completion Date

July 1, 2025

Study Completion Date

July 1, 2026

Conditions

Heart Failure

Interventions

DEVICE

CardioPumlonary Management System (CPM)

The CPM Device measures and trends a variety of physiologic parameters including thoracic impedance, respiration rate, tidal volume, ECG (electrocardiogram), heart rate, and diastolic heart sounds, all in an unobtrusive patch form factor.

Trial Locations (1)

33173

Baptist Health South Florida, Miami

All Listed Sponsors

lead

Analog Device, Inc.

OTHER

NCT06078267 - Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure (Beta Study) | Biotech Hunter | Biotech Hunter